FINWIRES · TerminalLIVE
FINWIRES

CIBCによると、市場はカナダの予想外の貿易黒字よりも原油価格に大きく反応している。

By

-- 火曜日に発表されたデータを受け、CIBCは、原油価格の上昇と金取引の好調を背景に、カナダの3月の貿易収支が予想外の黒字に転じたと発表した。 しかし、輸出量の改善はそれほど顕著ではなく、四半期全体で見ると、純貿易は依然として第1四半期の国内総生産(GDP)をわずかに押し下げる要因となっていると、同行は指摘した。 3月の貿易収支は18億ドルの黒字となり、前月の51億ドルの赤字、そして市場予想の25億ドルの赤字を大きく上回ったと、CIBCは指摘した。 同行は、経済指標の大幅な好転にもかかわらず、市場は経済指標よりも原油価格の変動に引き続き強く反応していると述べた。 3月の貿易黒字は予想外だったものの、その主な要因は価格変動であり、実体経済活動が予想以上に活発だったことを示す兆候はなかったと、CIBCは付け加えた。 先週、ガソリン価格の上昇がすでに消費支出に悪影響を与え始めている兆候が見られたことを踏まえ、カナダ銀行は今年のGDP成長率を緩やかなものにとどめ、経済の余剰生産能力が吸収されている兆候はほとんど見られないと引き続き予想している。 CIBCによると、こうした状況から、カナダ銀行は短期的なインフレ率の急上昇を見送り、今年の金利を据え置く見込みだ。

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE